Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups

Susana Vives, Pau Montesinos, Mireia Morgades et al.|Cancers|2024

Cited by 4